Mr. Borkowski, was appointed Interim Chief Financial Officer on June 6, 2018. He previously served as Executive Vice President of MiMedx since April 19, 2018. Prior to joining the Company, Mr. Borkowski served as the Chief Financial Officer of Aceto Corporation, an international company engaged in the development, marketing, sales and distribution of pharmaceutical products, from February 2018 until April 2018. Prior thereto, he held several executive level positions with Concordia International Corp., an international specialty pharmaceutical company, from 2015 to 2018, including serving as a Director, as Chief Financial Officer and as Executive Vice President. Previously, Mr. Borkowski served as Chief Financial Officer at Amerigen Pharmaceuticals, a privately-held pharmaceutical company focused on generic products, from 2013 to 2016 and ConvaTec Group PLC, an international medical products and technologies company, from 2012 to 2013. Mr. Borkowski serves as the Chairman of AzurRx BioPharma,Inc. and is on the Boards of Acacia Pharma Group PLC and Co-Diagnostics Inc.. He is also a Trustee of Allegheny College, where he serves on the Executive Committee and is Chairman of the Budget Committee.
He is a Member of the American Institute of Certified Public Accountants and the New York State Society of CPAs. Mr. Borkowski holds a Bachelor of Science in Economics and Political Science from Allegheny College and a Master in Business Administration in Finance and Accounting from Rutgers University.